Prosight Management’s Assembly Biosciences ASMB Stock Holding History

Prosight Management’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-22,136	Closed	-$924K	–	40
2021 Q3	$924K	Buy	22,136 +9,712	+78%	+$407K	0.51%	37
2021 Q2	$578K	Buy	12,424 +7,716	+164%	+$382K	0.36%	40
2021 Q1	$260K	Buy	+4,708	New	+$312K	0.21%	37
2019 Q3	–	Sell	-16,667	Closed	-$2.7M	–	36
2019 Q2	$2.7M	Sell	16,667 -9,534	-36%	-$1.81M	1.36%	21
2019 Q1	$6.19M	Buy	26,201 +3,206	+14%	+$812K	2.71%	12
2018 Q4	$6.24M	Buy	22,995 +13,030	+131%	+$3.77M	3.22%	11
2018 Q3	$4.44M	Buy	9,965 +4,523	+83%	+$2.12M	2.48%	17
2018 Q2	$2.56M	Buy	+5,442	New	+$2.88M	1.88%	19

Other funds holding ASMB

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

AIM

Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Prosight Management's ASMB Position: Q4 2021 in Review

Prosight Management sold out of Assembly Biosciences (ASMB) in Q4 2021, closing a stake of 22,136 shares — an estimated $924K sold.

Prosight Management first reported a position in ASMB in Q2 2018 and held it in 8 quarters. The position peaked at $6.24M in Q4 2018. 62 funds tracked by Wall St. Rank hold ASMB as of Q4 2021.

Prosight Management reported no remaining Assembly Biosciences position as of Q4 2021 after selling out during the quarter.
Prosight Management sold 22,136 Assembly Biosciences shares in Q4 2021, an estimated $924K.
Prosight Management first reported a position in Assembly Biosciences in Q2 2018 and held it in 8 quarters.
Prosight Management's Assembly Biosciences position peaked at $6.24M in Q4 2018.
62 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2021.

Based on Prosight Management's 13F filing for Q4 2021, filed 14 Feb 2022.